eFoodSafety.com, Inc. Reports 300% Revenue Growth Year-Over-Year for Its Fiscal Third Quarter

Scottsdale, AZ - (WORLD STOCK WIRE) - March 18, 2008 -- eFoodSafety.com, Inc. (OTCBB: EFSF) a developer of nutraceutical and whole food products reports its quarterly results for the company’s fiscal third quarter ended January 31, 2008, including year-over-year revenue growth of over 300%.

The company made significant progress during the quarter including ramping up sales and preparing to launch direct response marketing campaigns for several of its products. Financial highlights for the third quarter ended January 31, 2008 as compared with the third quarter ended January 31, 2007 are as follows:

Revenue increased 300% year-over-year: net sales were $309,197 for the quarter ended January 31, 2008 as compared to $82,930 for the same period ended January 31, 2007.
Sales and marketing expenses decreased 52% year-over-year: net sales and expenses were $28,455 for the quarter ended January 31, 2008 as compared to $54,387 for the same period ended January 31, 2007.

Research and development expenses decreased 83% year-over-year: R&D expenses were $8,381 for the quarter ended January 31, 2008 as compared with $49,051 for the same period ended January 31, 2007.

General and administrative expenses increased approximately 15.6% year-over-year due to higher insurance costs and increased liability limits for all divisions, stemming from increased product sales: G&A expenses were $222,756 for the quarter ended January 31, 2008 as compared to $192,615 for the same period ended January 31, 2007.

Management Comment

Patricia Gruden, CEO and Chairman of eFoodSafety

“Reporting year-over-year quarterly revenue growth of 300% for our fiscal third quarter is an encouraging way to embark upon what management anticipates will be a very promising year for the Company, including solid revenue growth, especially in conjunction with the imminent launch of our direct response campaigns for Cinnergen™ and Cinnechol™. We have delivered on our goal of building the foundation to support our products through consumer rollouts and continued R&D. At the same time, we continued to control our expenses, and this quarter’s results certainly reflect our achievements in those efforts. We can proudly report to our shareholders and investment community that the majority of our products are ready for market. We continue to remain in a very strong financial position with over $1 million in cash on hand after disbursements for all expenses.

In addition to our financial achievements this quarter, we have gained significant traction and momentum in several other areas of our business, including new product rollout and new product development, which have contributed to the exciting position in which we find ourselves today. These other achievements include our partnerships with CPG Focus Consulting to launch Immune Boost Bars in key retail outlets and Repond2 Communications to launch direct response marketing campaigns for four of our other products.

Furthermore, we have shown progress on the R&D side of the business with our entrance into the bio- and nano-technologies space as a means to improve the delivery methods of our products and to broaden our opportunities to treat common health conditions that affect millions of people worldwide. We also reported very positive and encouraging results for Citroxin™ and its ability to eradicate H5N1 avian influenza in chick embryos. These developments demonstrate that our team remains committed to reaching new levels in all aspects of our business. We believe this is an exciting and pivotal time in eFoodSafety’s development. We are pleased that this quarter’s results illustrate our growth and how well-positioned we are to capitalize on the progress that we have made.”

About eFoodSafety.com

eFoodSafety.com, Inc., based in Scottsdale, Arizona, is dedicated to improving health conditions around the world through its innovative technologies. The company’s Knock-Out Technologies, Ltd. subsidiary has developed an environmentally safe sporicidal product formulated entirely of food-grade components that eradicates anthrax and a germicidal product, Citroxin™ (formerly named Big Six Plus) – EPA Reg. No. 82723-1 that kills six major bacteria: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, Avian Influenza, and Black Mold. The sporicidal product has completed its final efficacy laboratory study requisite for EPA registration. In the study, it eradicated both Clostridium Sporogenes and Bacillus Subtilis with 100% efficacy on both hard and porous surfaces. The OraPhyte™ product, which has been tested and shown to be effective at eradicating nematodes by the U.S. Department of Agriculture, is currently at three major universities with outstanding Agricultural Departments undergoing crop-specific research.

The company’s Cinnergen™ is a clinically-researched, non-prescription liquid whole food nutritional supplement that promotes healthy glucose metabolism, is available for sale at (www.cinnergen.com) and through national retailers; its Cinnechol™ is a multi-faceted nutritional supplement specifically designed to naturally promote reduction in total cholesterol levels without causing any side effects, as well as overall cardiovascular health. The company has entered into a joint venture agreement with CK41 Direct, Inc. to launch the PurEffect™ anti-acne skin care system.

The company’s iBoost, Inc. subsidiary is the distributor of the Immune Boost Bar™, a non-dairy, no refined sugar, all-natural and comprehensive multi-nutrient product that helps fortify the body’s immune system. The product contains Citroxin O2™, eFoodSafety’s proprietary all natural supplement proven effective in fighting several types of harmful bacteria, and forty active compounds that assist with enhancing immunity, detoxification, cleansing, and metabolic efficiency. The Immune Boost Bar™ is available in four delicious flavors: chocolate, oatmeal-raisin, chocolate mint and peanut butter and can be purchased at www.immuneboost.com.

The company’s MedElite, Inc. subsidiary distributes clinically proven products to physicians who then prescribe the products for their patients. It is the owner of the Talsyn™-CI/bid Scar Cream, a product that has been clinically proven to facilitate and improve the appearance, redness and strength of scars (www.talsyn.com), as well as seven (7) other products in the Talsyn™ line.

Please visit the company’s website at: http://www.efoodsafety.com.

Safe Harbor Forward-Looking Statements

Statements contained in this release that are not strictly historical are “forward-looking statements.” Such forward-looking statements are sometimes identified by words such as “intends,” “anticipates,” “believes,” “expects” and “hopes.” The forward-looking statements are made based on information available as of the date hereof, and the Company assumes no obligation to update such forward-looking statements. Editors and investors are cautioned that such forward-looking statements involve risks and uncertainties that could cause the Company’s actual results to differ materially from those in these forward-looking statements. Such risks and uncertainties include but are not limited to demand for the Company’s products and services, our ability to continue to develop markets, general economic conditions, our ability to secure additional financing for the Company and other factors that may be more fully described in reports to shareholders and periodic filings with the Securities and Exchange Commission.



Patricia Gruden
efoodsafety.com, Inc.
7702 East Doubletree Ranch Road
Suite 300
Scottsdale, AZ 85258
USA

Phone: 415-884-0348
Fax: 480-348-3999


Source: efoodsafety.com, Inc.
Note: The following press release was submitted by: efoodsafety.com, Inc., and World Stock Wire, Inc. is not liable for the contents of this press release.